The company is going to market this product under the brand name ‘Jubi-R’ in India. The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment in India through its distribution network.

Yesterday’s session proved to be Black Monday for the Indian markets as both Sensex and Nifty glided below their important psychological level of 37,000 and 11,000, respectively. However, the bulls on D-Street would attempt for revival on Tuesday, aided by the joyful mood amongst the global peers.

If Nifty manages to close below the 200-DMA, the next level of meaningful support would be placed at 10,550. Interestingly, the 61.8 per cent retracement of the current upswing is also at 10,860. Stocks in news: Jubilant Life Sciences, Alembic Pharmaceuticals, Infosys.

Sovereign Gold Bond Scheme 2020-21 is now open for subscription. Should you subscribe to it? Let's find out.

Considering the daily timeframe, the stock of Tata Motors Limited has given a downward sloping trendline breakout along with robust volume. The stock has also managed to close above the upper Bollinger band and started the band walk, which is a very bullish sign.

The month of August has begun with strong bearish sentiments prevalent in the domestic markets as Sensex slumped by 667.29 points or 1.77 per cent to close at 36,939.60 while Nifty tanked by 173.60 points or 1.57 per cent to settle at 10,899.85.

With these orders, the company’s order book as on June 2020, stood at 759 KMT valued at almost Rs 6,200 crore. These order books translate into book-to-bill of 0.62x on TTM revenue, giving healthy revenue visibility in the near term

The stock of Procter & Gamble Health Limited has given an ascending triangle pattern breakout on the daily timeframe. This breakout is confirmed by the above 50-day average volume.

Wockhardt, the global pharmaceutical and biotechnology major, on Monday, announced that it has entered into an agreement with the UK Government to fill-finish COVID-19 vaccines.

Provisions and contingencies declined by 20.9 per cent YoY to Rs 1,512.07 crore in Q1FY21, as against Rs 1,911.98 crore in Q1FY20.